Baudax Bio Inc (NASDAQ:BXRX) is trading in green after news on Monday. BRBX climbed higher than it has in a week. There may be some upside here.
As of 3:38, BXRX is trading at $0.8431 up .033, gaining 4.07%. So far more than 898K shares have exchanged hands. The stock opened at $0.82 and moved within a narrow range of $0.8200-0.8742.
BXRX Announces Data of ANJESO®
Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal of Pain Management
- BXRX announced that the results of the Phase IIIb study evaluating ANJESO (meloxicam) injection administered preoperatively prior to colorectal surgery were published online in the journal Pain Management.
- ANJESO is the Company’s marketed, non-opioid, once daily, intravenous (IV) non-steroidal anti-inflammatory (NSAID) agent for use in adults for the management of moderate to severe pain that is indicated for use alone or in combination with other non-NSAID analgesics.
- “Adequate pain relief is an important component of ERAS (enhanced recovery after surgery) protocols and is associated with various beneficial effects, including shorter length of stay (LOS), enhanced recovery, faster mobilization and better patient satisfaction,” said Jennifer Silinsky, MD, Colorectal Surgeon, Tulane University School of Medicine, and lead author of the manuscript.
|SHARES OUTSTANDING||70.15 M|
|SHARE FLOAT (%)||69.08 M (98.48%)|
|% HELD BY INSTITUTIONS||16.89|
|CCI20||-103.1629||Sell||Chaikin Money Flow||-0.1458||Sell|
|MACD||-0.1223||Sell||Money Flow Index||26.4441||Sell|
|STOCH (14,3)||13.9767||OverSold||STOCH RSI||0.8694||OverBought|